Authors: Jirathitikal, Vichai¹; Bourinbaiar, Aldar S.²

Source: International Journal of Biotechnology, Volume 9, Numbers 3-4, 27 June 2007 , pp. 318-331(14)

Publisher: Inderscience Publishers

Abstract:

The safety of V-1 Immunitor (V1) has been investigated. L929; BHK; Vero; Caco-2 and CEM-SS cells have not shown cytotoxicity even at 10 mg/ml dose. Ames' mutagenicity and micronucleus genotoxicity tests came out negative at 50 mg and 2000 mg/kg doses in Salmonella and bone marrow of IRC mice. Acute and chronic dosing of V1 to Swiss albino mice and Spague Dawley rats failed to cause any deaths. The LD50 is higher than 26.66 g/kg daily dose of V1, which corresponds to 1.9 kg or 2200 V1 pills. Liver and kidney and other biochemical and blood parameters remained normal. In Phase I study about 9% of HIV-positive patients reported mild adverse reactions which did not last more than one week. Over 70,000 individuals have safely used V1 in past six years. Thus V1 is safe and the risk of toxicity or adverse events is negligible compared to the clinical benefit.

Keywords: TECHNICAL JOURNALS; Biosciences and Bioinformatics; ENVIRONMENTAL JOURNALS; Environment and Sustainable Development

Document Type: Research article

DOI: http://dx.doi.org/10.1504/IJBT.2007.014250

Affiliations: 1: Immunitor Corporation, Co. Ltd., 71 Moo 5, Bangpakong Industrial Park, Takarm, Chachoengsao 24130, Thailand. 2: Immunitor USA Inc., College Park, MD 20740, USA

Publication date: 2007-06-27

More about this publication?

• The International Journal of Biotechnology provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Terms & Conditions
• Newsletter
• Blog
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Biotechnology
• By this author: Jirathitikal, Vichai ;  Bourinbaiar, Aldar S.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers